| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 159.60B | 164.91B | 155.84B | 148.59B | 150.96B | 148.07B |
| Gross Profit | 49.76B | 53.36B | 47.23B | 45.04B | 46.13B | 44.79B |
| EBITDA | 14.32B | 16.21B | 12.03B | 12.85B | 13.35B | 12.72B |
| Net Income | 7.48B | 7.70B | 6.04B | 6.74B | 6.72B | 6.02B |
Balance Sheet | ||||||
| Total Assets | 145.19B | 155.78B | 147.84B | 147.09B | 139.93B | 134.08B |
| Cash, Cash Equivalents and Short-Term Investments | 41.10B | 49.65B | 42.16B | 40.60B | 42.18B | 38.57B |
| Total Debt | 5.70B | 6.37B | 6.57B | 6.61B | 6.55B | 5.21B |
| Total Liabilities | 42.67B | 48.22B | 45.94B | 47.82B | 46.58B | 44.24B |
| Stockholders Equity | 102.38B | 107.41B | 101.70B | 99.08B | 93.16B | 89.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.89B | 6.46B | 4.44B | 9.68B | 12.38B |
| Operating Cash Flow | 0.00 | 16.13B | 7.57B | 6.47B | 11.13B | 13.50B |
| Investing Cash Flow | 0.00 | -5.25B | -2.02B | -4.71B | -8.33B | -1.35B |
| Financing Cash Flow | 0.00 | -3.40B | -4.05B | -3.41B | -3.14B | -4.79B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥109.37B | 14.19 | ― | 1.71% | 5.83% | 28.78% | |
70 Outperform | ¥916.66B | 21.98 | 5.45% | 1.30% | 5.29% | 30.89% | |
70 Outperform | ¥33.69B | 6.07 | ― | 1.67% | 4.43% | 77.98% | |
69 Neutral | ¥754.29B | 11.82 | 6.38% | 1.03% | 8.01% | 103.83% | |
64 Neutral | ¥327.93B | 6.57 | 7.48% | 1.79% | 6.94% | 57.98% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
53 Neutral | ¥571.08B | 25.92 | -2.45% | 1.40% | -6.99% | -148.41% |